Oncternal Therapeutics (ONCT) Earnings Date, Estimates & Call Transcripts $1.14 +0.03 (+2.70%) (As of 11/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Oncternal Therapeutics Latest Earnings SummaryUpcoming Q3 Earnings DateMar. 6EstimatedActual EPS (Aug. 8) -$2.89 Beat By $0.14 Consensus EPS (Aug. 8) -$3.03 Oncternal Therapeutics posted Q2 2024 earnings on August 8, 2024, reporting an EPS of -$2.89, which beat analysts' consensus estimates of -$3.03 by $0.14. Quarterly revenue was reported to be $0.80 million, above the consensus estimate of $0.24 million. With a trailing EPS of -$11.69, Oncternal Therapeutics' earnings are expected to grow next year, from ($12.43) to ($10.25) per share. Conference Call TranscriptConference Call AudioONCT Upcoming EarningsOncternal Therapeutics' next earnings date is estimated for Thursday, March 6, 2025, based off prior year's reporting schedules. Get Oncternal Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oncternal Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataONCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ONCT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIDo this if you missed cheap BitcoinDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Because a new blockchain is taking the world by storm… It’s seeing rapid adoption amongst crypto fans… And just now starting to break into the mainstream. While I cannot promise future returns or against losses… This might not just be another chance at Bitcoin-like gains… It could be EVEN bigger. But this market is moving fast… So if you want a shot at getting in on what could be the ground floorClick Here for Details. Oncternal Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$3.30-$2.59-$2.95Q2 20242-$3.15-$2.52-$2.84Q3 20242-$2.74-$2.26-$2.50Q4 20242-$2.38-$2.19-$2.29FY 20248-$11.57-$9.56-$10.57Q1 20251-$2.42-$2.42-$2.42Q2 20251-$2.19-$2.19-$2.19Q3 20251-$2.00-$2.00-$2.00Q4 20251-$2.05-$2.05-$2.05FY 20254($8.66)($8.66)($8.66) Oncternal Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/6/2025(Estimated)------- 8/8/2024Q2 2024-$3.03-$2.89+$0.14-$2.89$0.24M$0.80M 5/9/2024Q1 2024-$2.88-$2.83+$0.05-$2.83$0.18M$0.57M 3/7/2024Q4 2023-$3.09-$3.11 -$0.02-$3.11$0.17M$0.30M 11/9/2023Q3 2023-$3.00-$3.40 -$0.40-$0.17$0.17M$0.18M 8/10/2023Q2 2023-$3.40-$3.00+$0.40-$0.15$0.21M$0.11M5/4/2023Q1 2023-$4.20-$4.00+$0.20-$0.20$0.20M$0.20M Get the Latest News and Ratings for ONCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/9/2023Q4 2022-$4.40-$4.00+$0.40-$0.20$0.37M$0.17M Oncternal Therapeutics Earnings - Frequently Asked Questions When is Oncternal Therapeutics's earnings date? Oncternal Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates. Learn more on ONCT's earnings history. Did Oncternal Therapeutics beat their earnings estimates last quarter? In the previous quarter, Oncternal Therapeutics (NASDAQ:ONCT) reported ($2.89) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.03) by $0.14. Learn more on analysts' earnings estimate vs. ONCT's actual earnings. How can I listen to Oncternal Therapeutics's earnings conference call? The conference call for Oncternal Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Oncternal Therapeutics's conference call transcript? The conference call transcript for Oncternal Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Oncternal Therapeutics generate each year? Oncternal Therapeutics (NASDAQ:ONCT) has a recorded annual revenue of $790,000.00. How much profit does Oncternal Therapeutics generate each year? Oncternal Therapeutics (NASDAQ:ONCT) has a recorded net income of -$39.48 million. ONCT has generated -$11.69 earnings per share over the last four quarters. What is Oncternal Therapeutics's EPS forecast for next year? Oncternal Therapeutics's earnings are expected to grow from ($12.43) per share to ($10.25) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies PharmaCyte Biotech Earnings Date Mannatech Earnings Date ProPhase Labs Earnings Date Sensei Biotherapeutics Earnings Date ImmunoPrecise Antibodies Earnings Date NRx Pharmaceuticals Earnings Date Aspira Women's Health Earnings Date Turnstone Biologics Earnings Date Avalo Therapeutics Earnings Date ANEW Medical Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Do this if you missed cheap Bitcoin (Ad)Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Because a new blockchain is taking the world by storm… It’s seeing rapid adoption amongst crypto fans… And just now starting to break into the mainstream. While I cannot promise future returns or against losses… This might not just be another chance at Bitcoin-like gains… It could be EVEN bigger. But this market is moving fast… So if you want a shot at getting in on what could be the ground floorClick Here for Details. This page (NASDAQ:ONCT) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncternal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncternal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
